Cargando…
Change in Bacterial Diversity of Fecal Microbiota Drives Mortality in a Hamster Model of Antibiotic-induced Clostridium difficile Colitis
BACKGROUND: C. difficile (C diff) infection results from antibiotic-induced changes in colonic microbiota. DAV131A, an oral adsorbent-based product, can sequester antibiotic (AB) residues in the gut and reduce mortality in a hamster model of moxifloxacin (MXF) or clindamycin (CM) induced C diffcolit...
Autores principales: | Burdet, Charles, Nguyen, Thu Thuy, Saint-Lu, Nathalie, Sayah-Jeanne, Sakina, Hugon, Perrine, Sablier-Gallis, Frédérique, Ferreira, Stéphanie, Andremont, Antoine, Mentré, France, Gunzburg, Jean De |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631430/ http://dx.doi.org/10.1093/ofid/ofx163.947 |
Ejemplares similares
-
Mathematical Modeling of Bacterial Kinetics to Predict the Impact of Antibiotic Colonic Exposure and Treatment Duration on the Amount of Resistant Enterobacteria Excreted
por: Nguyen, Thu Thuy, et al.
Publicado: (2014) -
O012: Can DAV132, a medical device targeting an adsorbent to the late ileum, decrease significantly the impact of antibiotics on the fecal microbiota?
por: Grall, N, et al.
Publicado: (2013) -
Protection of the Human Gut Microbiome From Antibiotics
por: de Gunzburg, Jean, et al.
Publicado: (2018) -
Susceptibility of Hamsters to Clostridium difficile Isolates of Differing Toxinotype
por: Buckley, Anthony M., et al.
Publicado: (2013) -
Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics
por: van Werkhoven, Cornelis H., et al.
Publicado: (2021)